|
|
|
|
Strain
Number: |
01XL9 |
Common
Strain Name: |
p53 R172H |
Strain
Nomenclature: |
129S4-Trp53tm2.1Tyj |
|
|
|
Release
Category (Required for MTA form):
B,D
|
|
Animal Health Report in PDF Format |
|
|
|
|
|
|
|
|
Strain
Description: |
These mice express point-mutant p53 under control of the endogenous Trp53 promoter. Heterozygous mice have an increased tumor burden relative to Trp53+/- mice but similar survival curves. The animals show a broad tumor spectrum with an increased frequency of carcinomas, osteosarcomas, hemangiosarcomas, and lymphoblastic lymphomas. Osteosarcomas are more frequently metastatic. An improved model for Li-Fraumeni Syndrome. |
|
|
|
|
Mutation
Information |
|
|
Mutation
Type: |
Targeted |
|
Gene
Name: |
Transformation related protein 53
|
|
Gene
Symbol: |
Trp53
|
|
Transgene
Name: |
|
|
Transgene
Symbol: |
|
|
Promoter
Name: |
|
|
Promoter
Symbol: |
|
|
Current
Genetic Background: |
129S4/SvJae |
|
Approx.
Generation: |
6 |
|
Organ
Site : |
multiple |
|
|
|
|
Cryopreservation Mating Scheme: |
129S4 females x heterozygous males |
|
Genotyping Information: |
Protocol 1: Allele: Trp53
|
|
|
|
|
Donating
Investigator: |
Dr. Tyler Jacks |
Key
Reference: |
Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell. 2004 Dec 17;119(6):847-60.
PMID: 15607980
[PubMED
Abstract]
|
|
|
|
|
|
|
|
|
|